CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial.
Saved in:
| Title: | CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial. |
|---|---|
| Authors: | He, W.1,2,3, Eriksson, M.3, Eliasson, E.4, Grassmann, F.3,5, Bäcklund, M.3, Gabrielson, M.3, Hammarström, M.3, Margolin, S.6,7, Thorén, L.6,7, Wengström, Y.8, Borgquist, S.9,10, Hall, P.1,3,6 per.hall@ki.se, Czene, K.3 |
| Source: | Annals of Oncology. Oct2021, Vol. 32 Issue 10, p1286-1293. 8p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152693892 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22He%2C+W%2E%22">He, W.</searchLink><relatesTo>1,2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Eriksson%2C+M%2E%22">Eriksson, M.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Eliasson%2C+E%2E%22">Eliasson, E.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Grassmann%2C+F%2E%22">Grassmann, F.</searchLink><relatesTo>3,5</relatesTo><br /><searchLink fieldCode="AR" term="%22Bäcklund%2C+M%2E%22">Bäcklund, M.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Gabrielson%2C+M%2E%22">Gabrielson, M.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Hammarström%2C+M%2E%22">Hammarström, M.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Margolin%2C+S%2E%22">Margolin, S.</searchLink><relatesTo>6,7</relatesTo><br /><searchLink fieldCode="AR" term="%22Thorén%2C+L%2E%22">Thorén, L.</searchLink><relatesTo>6,7</relatesTo><br /><searchLink fieldCode="AR" term="%22Wengström%2C+Y%2E%22">Wengström, Y.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Borgquist%2C+S%2E%22">Borgquist, S.</searchLink><relatesTo>9,10</relatesTo><br /><searchLink fieldCode="AR" term="%22Hall%2C+P%2E%22">Hall, P.</searchLink><relatesTo>1,3,6</relatesTo><i> per.hall@ki.se</i><br /><searchLink fieldCode="AR" term="%22Czene%2C+K%2E%22">Czene, K.</searchLink><relatesTo>3</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Oct2021, Vol. 32 Issue 10, p1286-1293. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152693892 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2021.07.005 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 1286 Titles: – TitleFull: CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: He, W. – PersonEntity: Name: NameFull: Eriksson, M. – PersonEntity: Name: NameFull: Eliasson, E. – PersonEntity: Name: NameFull: Grassmann, F. – PersonEntity: Name: NameFull: Bäcklund, M. – PersonEntity: Name: NameFull: Gabrielson, M. – PersonEntity: Name: NameFull: Hammarström, M. – PersonEntity: Name: NameFull: Margolin, S. – PersonEntity: Name: NameFull: Thorén, L. – PersonEntity: Name: NameFull: Wengström, Y. – PersonEntity: Name: NameFull: Borgquist, S. – PersonEntity: Name: NameFull: Hall, P. – PersonEntity: Name: NameFull: Czene, K. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: Oct2021 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 32 – Type: issue Value: 10 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |